Laboratory Corporation of America Holdings (LH)

Last Price: 183.40 (2020-09-18)

Company Description

Laboratory Corporation of America Holdings is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $11.55B
Net Income (Most Recent Fiscal Year) $823.80M
PE Ratio (Current Year Earnings Estimate) 13.04
PE Ratio (Trailing 12 Months) 17.11
PEG Ratio (Long Term Growth Estimate) 1.52
Price to Sales Ratio (Trailing 12 Months) 1.55
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 2.42
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 9.42
Pre-Tax Margin (Trailing 12 Months) 5.31%
Net Margin (Trailing 12 Months) 3.16%
Return on Equity (Trailing 12 Months) 14.39%
Return on Assets (Trailing 12 Months) 5.91%
Current Ratio (Most Recent Fiscal Quarter) 1.12
Quick Ratio (Most Recent Fiscal Quarter) 1.01
Debt to Common Equity (Most Recent Fiscal Quarter) 0.75
Inventory Turnover (Trailing 12 Months) 31.04
Book Value per Share (Most Recent Fiscal Quarter) $77.93
Earnings per Share (Most Recent Fiscal Quarter) $2.57
Earnings per Share (Most Recent Fiscal Year) $11.32
Diluted Earnings per Share (Trailing 12 Months) $3.67
Stock
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Common Shares Outstanding 97.40M
Free Float 96.72M
Market Capitalization $17.83B
Average Volume (Last 20 Days) 0.85M
Beta (Past 60 Months) 1.32
Percentage Held By Insiders (Latest Annual Proxy Report) 0.70%
Percentage Held By Institutions (Latest 13F Reports) 88.65%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%